drugset / Trial / NCT04780581
Glucocorticoid Therapy in Coronavirus Disease COVID-19 Patients
Phase 4
Terminated
128 enrolled
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Instituto de Investigación Biomédica de Salamanca · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Treatment with glucocorticoids in COVID patients. Low-intervention, phase IV, open-label, randomised, low-intervention clinical trial comparing 2 active treatments.
Timeline
- Start
- 2021-02-01
- Primary completion
- 2021-11-09
- Completion
- 2021-11-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexamethasone | Small molecule | 6 mg | — |
| Subject | Methylprednisolone | Other / unclassified | 250 mg | — |